The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health

by Robert F. Kennedy Jr.

In 1991, four years later, Lauritsen filed a Freedom of Information request asking for various FDA documents pertaining to the Phase II AZT trials—most importantly, the “Establishment Inspection Report” on the Boston center, written by FDA investigator Patricia Spitzig. After months of lies, evasions, and obstructions from the FDA, a courageous female FDA whistleblower breached all the stonewalling and saw to it that Lauritsen got the Spitzig Report.97 It was a bombshell: As it turned out, the Boston Principal Investigators (PIs) cheated on almost every patient. The Burroughs Wellcome PIs had quickly realized that AZT was so reliably deadly that they were hard-pressed to keep the trial recruits alive for the full six-month study. The Boston team solved this dilemma by lying about the length of time patients were in the trials. The company incentivized this sort of fraud by paying its PIs according to how many months they kept the AZT trial subjects alive. “Simply put,” says Lauritsen, “the doctors received a great deal more money,” from longer-term enrollments. Pharma PIs know that their careers and paychecks depend on their ability to consistently produce study outcomes that will win FDA approval for the subject drug. Such perverse incentives naturally drive research bias, confirmation bias, data tampering, strategic laziness, and deliberate falsification and cheating. PIs routinely covered up adverse events, violated protocols, falsely reported AZT patients as being plac...